Changes in serum thyroid hormone, thyrotropin and thyroglobulin concentrations during thyroxine therapy in patients with solitary thyroid nodules

Journal of Clinical Endocrinology and Metabolism

Volumn 69, Issue 2, 1989, Pages 227-230

  Morita, Tetsuya ^a   Tamai, Hajime ^a   Ohshima, Akira ^a   Komaki, Gen ^a   Matsubayashi, Sunao ^a   Kuma, Kanji ^b   Nakagawa, Tetsuya ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KUMA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; RADIOISOTOPE; THYROGLOBULIN; THYROXINE;

ADULT; CLINICAL ARTICLE; ECHOGRAPHY; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SERUM; THYROID NODULE;

ADOLESCENT; ADULT; AGED; FEMALE; GOITER, NODULAR; HUMAN; MALE; MIDDLE AGE; THYROGLOBULIN; THYROID FUNCTION TESTS; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 0024348379     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem-69-2-227     Document Type: Article

References (18)

1. Hansen JM, Kampmann J, Madsen SN, et al. L-Thyroxine treatment of diffuse non-toxic goiters evaluated by ultrasonic determination of thyroid volume. Clin Endocrinol (Oxf). 1979;10:1-6.
2. Gharib H, James EM, Charboneau JW, Naessens JM, Offord KP, Gorman CA. Suppressive therapy with levothyroxine for solitary thyroid nodules. A double-blind controlled clinical study. N Engl J Med. 1987;317:70-5.
3. Schneeberg NG, Stahl TJ, Maldia G, Menduke H. Regression of goiter by whole thyroid or triiodothyronine. Metabolism. 1962;11:1054-60.
4. Shimaoka K, Sokal JE. Suppressive therapy of nontoxic goiter. Am J Med. 1974;57:576-83.
5. Greenspan FS. Thyroid nodules and thyroid cancer. West J Med. 1974;121:359-65.
6. Thomas Jr CG, Buckwalter JA, Stabb EV, Kerr CY. Evaluation of dominant thyroid masses. Ann Surg. 1976;183:463-9.
7. Burrow GN, Mujtaba Q, LiVolsi V, Comog J. The incidence of carcinoma in solitary “cold” thyroid nodules. Yale J Biol Med. 1978;51:13-7.
8. Blum M, Rothschild M. Improved nonoperative diagnosis of the solitary “cold” thyroid nodule: surgical selection based on risk factors and three months of suppression. JAMA. 1980;243:242-5.
9. Liechty RD, Stoffel PT, Zimmerman DE, Silverberg SG. Solitary thyroid nodules. Arch Surg. 1981;112:59-61.
10. Clark OH. TSH suppression in the management of thyroid nodules and thyroid cancer. World J Surg. 1981;5:39-47.
11. Westermark K, Westermark B, Karlsson FA, Ericson LE. Location of epidermal growth factor receptors on porcine thyroid follicle cells and receptor regulation by thyrotropin. Endocrinology. 1986;118:1040-6.
12. Staffan S, Hans JP, Hans G, Erik J, Sten L, Hugo S. Effects of thyroxine on cell proliferation in human multinodular goiter: A study on the growth of thyroid tissue transplanted to nude mice. World J Surg. 1988;12:241-52.
13. Unger J, Van Heuverswyn B, Decoster C, Cantraine F, Mockel J, Van Herle A. Thyroglobulin and thyroid hormone release after intravenous administration of bovine thyrotropin in man. J Clin Endocrinol Metab. 1980;51:590-4.
14. Uller RP, Van Herle AJ, Chopra IJ. Comparison of alteration in circulating thyroglobulin triiodothyronine and thyroxine in response to exogenous (bovine) and endogenous (human) thyrotropin. J Clin Endocrinol Metab. 1973;37:741-5.
15. Van Herle AJ, Uller RP. Elevated serum thyroglobulin. A marker of métastasés in differentiated thyroid carcinomas. J Clin Invest. 1975;56:272-7.
16. Yamashita S, Izumi M, Kobo I, et al. Human serum thyroglobulin and thyroid nodules. Folia Endocrinol Jpn. 1981;57:930-40.
17. Ikekuba K, Hamasaki T, Yamada A, et al. Clinical usefullness of the measurement of serum thyroglobulin in patients with thyroid tumors. Jpn J Nucl Med. 1983;20:313-29.
18. Dralle H, Bocker W, Dohler KD, et al. Growth and function of thirty-four human benign and malignant thyroid xenografts in untreated nude mice. Cancer Res. 1985; 45:1239-45.